XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Collaboration Agreements - Sanofi (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 36 Months Ended
Jun. 30, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Dec. 31, 2020
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Collaboration revenue from customers   $ 5,285,000 [1] $ 9,388,000 $ 36,143,000 [1] $ 18,751,000    
Sanofi | Collaborative Arrangement              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Receivable   0   0   $ 0 $ 44,303
Sanofi | Collaborative Arrangement | Milestone Triggered              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Transaction price increase   0   15,000,000      
Collaboration revenue from customers $ 15,000,000         25,000,000  
Sanofi | Collaborative Arrangement | Milestone Triggered and Retained Activities              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Transaction price increase     $ 100,000   $ 900,000    
Sanofi | Collaborative Arrangement | Alzheimer's Disease Services              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Contract liability   $ 3,400,000   $ 3,400,000   3,400,000 $ 3,400,000
Sanofi | Collaborative Arrangement | Product              
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]              
Collaboration revenue from customers           $ 0  
[1] Includes related party collaboration revenue from a customer of $0.9 million and $2.5 million for the three and nine months ended September 30, 2021, respectively.